According to a new report, published by KBV research, The Global Allergy Diagnostics Market size is expected to reach $11.4 billion by 2028, rising at a market growth of 13.3% CAGR during the forecast period.
The Diagnostic Laboratories market is generating high revenue in the Global Allergy Diagnostics Market by End-user in 2021; thereby, achieving a market value of $5.2 billion by 2028. Growing diagnostic laboratory trends as a consequence of patients' requests for precise diagnoses and a rise in the demand for independent diagnostic laboratories are mainly responsible for the expansion in this segment. The public is becoming more aware of the treatment of allergic diseases and funding opportunities for the establishment of independent diagnostic laboratories.
The Food market is anticipated to grow at a CAGR of 13.9% during (2022 - 2028). This growth can be attribute from the fact that food allergies are a major cause of death across the globe. Shortness of breath, tongue or throat swelling, an itchy rash, and low blood pressure, and these symptoms can all appear very suddenly. Certain situations may be very harmful. Thus, the market would grow in the near future.
The In Vivo market has acquired maximum revenue in the Global Allergy Diagnostics Market by Test Type in 2021; thereby, achieving a market value of $6.6 billion by 2028. Organ challenge testing and skin tests are the two primary forms of in vivo allergy tests. Both are meant to prove hypersensitivity and identify the specific antigen that set off the allergic reaction. The adoption of different in vivo testing, like skin prick tests, is a key driver of this market's expansion. These tests are more reliable, safe, practical, and cost-effective than in vitro tests.
The Instruments market is experiencing a CAGR of 13.5% during (2022 - 2028). Market competitors regularly update a number of allergy diagnostic tools, including blot analyzers, ELISA analyzers, scanners, luminometers, and immunoassay analyzers. The diagnosis of allergies becomes more crucial as they become more common. As a result of this, the market for allergy diagnostics market would grow in this segment during the upcoming years.
The North America market region shows high market share in the Global Allergy Diagnostics Market by Region in 2021; thereby, achieving a market value of $4.3 billion by 2028. The Europe market would witness a CAGR of 12.9% during (2022 - 2028). Additionally, The Asia Pacific market is exhibiting a CAGR of 13.8% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/allergy-diagnostics-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Danaher Corporation, Hitachi chemical Diagnostic Inc., Hycor Biomedical Inc., Lincoln Diagnostics Inc., Omega Diagnostic Llc, Siemens Healthcare Diagnostics, Inc., Thermo Fisher Scientific Inc., Neogen Corporation, Eurofins Scientific Group, and ACON Laboratories, Inc.
By End-user
By Allergen
By Test Type
By Product & Services
By Geography
Companies Profiled
Unique Offerings 
